ORGANOCHLORIDE PESTICIDES IN MACEDONIAN GIRLS WITH PREMATURE SEXUAL DEVELOPMENT
Krstevska-Konstantinova M1,*, Kocova M1, Charlier C2, Bourguignon JP3
*Corresponding Author: Dr. Marina Krstevska Konstantinova, Pediatric Clinic, Department of Endocrinology and Genetics, Medical Faculty, Vodnjanska 17, 1000 Skopje, Republic of Macedonia; Tel.: +389-2-314-7474; Fax: +389-2-3225-809; E-mail: marina@lancom.com.mk
page: 43

RESULTS

Most girls who had PSD and the girls in the control group came from the capital, Skopje, and also from towns in the Republic of Macedonia. They were referred to the Pediatric Clinic by their family doctors. Figure 1 shows the towns in the Republic of Macedonia from which the girls (and numbers) originate.

Of the 56 girls with PSD, 42 had premature thelarche, five had early puberty, and nine had precocious puberty of idiopathic (n = 8) or organic (n = 1) origin. Traces of p,p’-DDE were found in nine girls (16%), while 41 (73%) had negative results and six (10%) had a mean value of 1.17 ± 0.7 µg/L. In the control group, traces of p,p’-DDE were found in one girl (4%), while 18 had negative results (75%) and five (20%) had a mean level of 1.18 ± 0.6 mg/L. There were no significant differences between the levels of p,p’-DDE in both groups. PSD: P1 = 14/56 = 0.25; controls: P2 = 6/4 = 0.25, P1-P2 = 0.

The mean level of lindane in the PSD group was 1.2 ± 0.8 µg/L, and in the control group 1.4 ± 0.8 µg/L. A significantly larger proportion of girls who tested positive for lindane in the control group (p <0.05) than in the PSD group (t = 0.39/0.121 = 3.233 t-test). This comparison was performed using unpaired Student’s t-test. PSD: P1 = 18/56 = 0.32; controls: P2 = 17/24 = 0.71, P1–P2 = 0.32– 0.71 = (0, 39), S P11p = 0.121 (standard error for both groups). Figure 2 shows the levels of lindane and p,p’-DDE in the PSD and control group.

Figure 1. Distribution of children with PSD by regions in the Republic of Macedonia.




Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006